Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

M&S estimates £300m hit from cyberattack as FY profits tank

(Sharecast News) - Marks & Spencer has said it expects current-year profits to take a £300m hit from a "highly sophisticated" cyber incident that has hampered operations over the past month. The attack has hit food sales through reduced availability, while waste and logistics costs have risen due to the need to operate manual processes. Meanwhile, ecommerce sales for fashion, home and beauty still remain paused, with M&S expecting online disruption to continue throughout June and into July.

"Therefore, our current estimate before mitigation is an impact on group operating profit of around £300m for 2025/26, which will be reduced through management of costs, insurance and other trading actions," the retailer said on Wednesday.

The news came alongside the retailer's annual results for the 12 months to 29 March - the financial year ended before the cyberattack in late-April - which revealed a 24% drop in statutory pre-tax profits to £511.8m, mainly due to a £248.5m impairment charge against its investment in Ocado Retail.

Excluding adjusting items, however, pre-tax profit improved by 22% year-on-year to £875.5m - hitting its highest level in over 15 years - with the company making £120m in structural cost reductions during the year.

Sales were 6.1% higher at £13.91bn, with food sales rising 8.7% to £9.0bn, and fashion, home and beauty sales up 3.5% at £4.2bn. International sales were down 7.1% on a constant currency basis at £0.7bn.

M&S raised its full-year dividend by 20% to 3.6p per share.

"[The cyber incident] has been challenging, but it is a moment in time, and we are now focused on recovery, with the aim of exiting this period a much stronger business," said chief executive Stuart Machin.

"There is no change to our strategy and our longer-term plans to reshape M&S for growth and, if anything, the incident allows us to accelerate the pace of change as we draw a line and move on."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.